𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Scribed by Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard D Gelber; for the International Breast Cancer Study Group and BIG 1-98 Collaborative Group


Book ID
118726736
Publisher
BioMed Central
Year
2011
Tongue
English
Weight
368 KB
Volume
13
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES